Unexplored therapeutic opportunities in the human genome
Nature Reviews Drug Discovery 17, 317 (2018).
doi:10.1038/nrd.2018.14
Authors: Tudor I. Oprea, Cristian G. Bologa, Søren Brunak, Allen Campbell, Gregory N. Gan, Anna Gaulton, Shawn M. Gomez, Rajarshi Guha, Anne Hersey, Jayme Holmes, Ajit Jadhav, Lars Juhl Jensen, Gary L. Johnson, Anneli Karlson, Andrew R. Leach, Avi Ma'ayan, Anna Malovannaya, Subramani Mani, Stephen L. Mathias, Michael T. McManus, Terrence F. Meehan, Christian von Mering, Daniel Muthas, Dac-Trung Nguyen, John P. Overington, George Papadatos, Jun Qin, Christian Reich, Bryan L. Roth, Stephan C. Schürer, Anton Simeonov, Larry A. Sklar, Noel Southall, Susumu Tomita, Ilinca Tudose, Oleg Ursu, Dušica Vidovic´, Anna Waller, David Westergaard, Jeremy J. Yang & Gergely Zahoránszky-Köhalmi
A large proportion of biomedical research and the development of therapeutics is focused on a small fraction of the human genome. In a strategic effort to map the knowledge gaps around proteins encoded by the human genome and to promote the exploration of currently understudied,
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Tudor I. Oprea Cristian G. Bologa S ΓΈ ren Brunak Allen Campbell Gregory N. Gan Anna Gaulton Shawn M. Gomez Rajarshi Guha Anne Hersey Jayme Holmes Ajit Jadhav Lars Juhl Jensen Gary L. Johnson Anneli Karlson Andrew R. Leach Avi Ma'ayan Anna Malovannaya Sub Tags: Analysis Source Type: research
More News: Drugs & Pharmacology